# A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis

> **NCT03614078** · PHASE2 · COMPLETED · sponsor: **PRCL Research Inc.** · enrollment: 92 (actual)

## Conditions studied

- Psoriasis Vulgaris
- Plaque Psoriasis

## Interventions

- **DRUG:** PRCL-02
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03614078
- **Lead sponsor:** PRCL Research Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-25
- **Primary completion:** 2019-04-29
- **Final completion:** 2019-07-08
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2020-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03614078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03614078, "A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03614078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*